USPCM
EGRX

Union Square Park Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Union Square Park Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56,963
Closed -$212K – 37
2024
Q3 		$212K Buy
+56,963
New +$212K 0.15% 24